These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28801077

  • 1. Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
    Pozo E, Castellano JM, Kanwar A, Deochand R, Castillo-Martin M, Pazos-López P, González-Lengua C, Osman K, Cham M, Cordon-Cardo C, Narula J, Fuster V, Sanz J.
    J Card Fail; 2018 Feb; 24(2):78-86. PubMed ID: 28801077
    [Abstract] [Full Text] [Related]

  • 2. Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
    Barison A, Aquaro GD, Pugliese NR, Cappelli F, Chiappino S, Vergaro G, Mirizzi G, Todiere G, Passino C, Masci PG, Perfetto F, Emdin M.
    J Intern Med; 2015 May; 277(5):605-14. PubMed ID: 25346163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E, Kanwar A, Deochand R, Castellano JM, Naib T, Pazos-López P, Osman K, Cham M, Narula J, Fuster V, Sanz J.
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
    aus dem Siepen F, Buss SJ, Andre F, Seitz S, Giannitsis E, Steen H, Katus HA, Kristen AV.
    Clin Res Cardiol; 2015 Aug; 104(8):640-7. PubMed ID: 25855392
    [Abstract] [Full Text] [Related]

  • 9. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
    Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Moon JC.
    Circ Cardiovasc Imaging; 2013 Jan 01; 6(1):34-9. PubMed ID: 23192846
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular magnetic resonance in cardiac amyloidosis.
    Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ.
    Circulation; 2005 Jan 18; 111(2):186-93. PubMed ID: 15630027
    [Abstract] [Full Text] [Related]

  • 11. Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac Amyloidosis.
    Cholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux JF.
    Acad Radiol; 2019 Jun 18; 26(6):e98-e107. PubMed ID: 30072291
    [Abstract] [Full Text] [Related]

  • 12. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
    Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY.
    JACC Cardiovasc Imaging; 2012 Sep 18; 5(9):897-907. PubMed ID: 22974802
    [Abstract] [Full Text] [Related]

  • 13. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, Lachmann HJ, Perlini S, Pontone G, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M.
    JACC Cardiovasc Imaging; 2020 Jan 18; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [Abstract] [Full Text] [Related]

  • 14. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil JP, Benhaiem N, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Mohty D, Deux JF, Damy T.
    JACC Cardiovasc Imaging; 2016 Feb 18; 9(2):126-38. PubMed ID: 26777222
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.
    Slivnick JA, Alvi N, Singulane CC, Scheetz S, Goyal A, Patel H, Sarswat N, Addetia K, Fernandes F, Vieira MLC, Cafezeiro CRF, Carvalhal SF, Simonetti OP, Singh J, Lang RM, Zareba KM, Patel AR.
    Eur Heart J Cardiovasc Imaging; 2023 May 31; 24(6):829-837. PubMed ID: 36624559
    [Abstract] [Full Text] [Related]

  • 18. Myocardial perfusion in cardiac amyloidosis.
    Chacko L, Kotecha T, Ioannou A, Patel N, Martinez-Naharro A, Razvi Y, Patel R, Massa P, Venneri L, Brown J, Porcari A, Knott K, Manisty C, Knight D, Lockie T, Rakhit R, Lachmann H, Wechelakar A, Whelan C, Ponticos M, Moon J, González A, Gilbertson J, Riefolo M, Leone O, Xue H, Hawkins P, Kellman P, Gillmore J, Fontana M.
    Eur J Heart Fail; 2024 Mar 31; 26(3):598-609. PubMed ID: 38247182
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types.
    Tavoosi A, Yu B, Aghel N, Karur GR, Pakkal M, Wald R, Wintersperger BJ, Delgado DH, Hanneman K.
    J Thorac Imaging; 2020 Sep 31; 35(5):334-339. PubMed ID: 32195888
    [Abstract] [Full Text] [Related]

  • 20. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis.
    Aquaro GD, Pugliese NR, Perfetto F, Cappelli F, Barison A, Masci PG, Passino C, Emdin M.
    Int J Cardiovasc Imaging; 2014 Aug 31; 30(6):1105-15. PubMed ID: 24789582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.